Scholarly Index
Kyle W. Sloop
Eli Lilly (United States); 7,241 total citations; 114 total publications; best world rank #94
Eli Lilly (United States)
7,241Total citations
114Total publications
46H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diabetes Treatment and Management | Lifetime | 676 | US 247 | 97.61 |
| Diabetes Treatment and Management | 2021-2025 | 299 | US 103 | 96.70 |
| Neuropeptides and Animal Physiology | 2021-2025 | 94 | US 31 | 92.22 |
| Pancreatic function and diabetes | 2021-2025 | 790 | US 266 | 88.81 |
| Receptor Mechanisms and Signaling | 2021-2025 | 477 | US 175 | 86.56 |
| Regulation of Appetite and Obesity | 2021-2025 | 685 | US 214 | 71.05 |
| Pharmacology and Obesity Treatment | 2021-2025 | 815 | US 313 | 62.45 |